CGT Adaptimmune: Your Trusted Thermo Fisher Supplier for Advanced Solutions

T&L Biotechnology Co., Ltd. is pleased to announce a strategic collaboration with CGT Adaptimmune to develop innovative cell and gene therapies for cancer treatment. Our joint effort will focus on advancing the development and commercialization of novel T-cell therapies to address unmet medical needs in oncology, At T&L Biotechnology Co., Ltd., we are committed to revolutionizing cancer treatment by leveraging our expertise in Cell Therapy technologies and manufacturing capabilities. Our collaboration with CGT Adaptimmune will combine their leading T-cell receptor technology with our advanced manufacturing platform to accelerate the delivery of promising treatments to patients in need, We are excited about the potential of this partnership to bring forth a new generation of cancer immunotherapies that have the potential to transform the way cancer is treated. Together with CGT Adaptimmune, we are dedicated to pushing the boundaries of what is possible in the fight against cancer and improving the lives of patients worldwide, Stay tuned for updates on our progress as we work towards advancing innovative cell and gene therapies for cancer treatment